CIP-003NCT07327528
Multicentric Pilot Study for the Application of an Endourethral Device for the Treatment of Stress Urinary Incontinence
At risk: Primary completion moved at least 6 months later.
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗
Notable Primary and study completion pushed from Dec 31, 2026 to Jun 30, 2027 Show 6 more changesShow less
- Enrollment reopened
- Enrollment increased: 20 → 30 participants
- Eligibility criteria expanded, about 31 words
- Study sites: 1 to 3
- Secondary endpoints: details revised at 1 of 1 entry
- Study title revised
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
The safety of UroRelief
Timeframe: 18 months
Secondary (1)
Assess incontinence at 30 days, measured using the 24-hour pad weight test.
Arms and interventions
Endoscopic surgery for device installationExperimental
Endoscopic surgery for device installation
Devices: UroRelief, a sterile, single-use, endourethral medical device suitable for both men and women, which is positioned at the bladder neck for the treatment of stress incontinence.
Sites
3 sites in 1 country